| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Marina Coelho Moraes de Brito, Maria Magalhães Vasconcelos Guedes, Janaíra da Silva Nascimento, Victoria Pimentel Jatobá, Murilo Pereira Alves Junior, Adrianne de Carvalho Lira, Pedro Alves da Cruz Gouvei. Diffuse Large B-Cell Lymphoma with Cutaneous Manifestations in a Young Patient Using Clozapine for Schizophrenia: A Case Report. The American journal of case reports. vol 24. 2023-11-21. PMID:37986560. |
diffuse large b-cell lymphoma with cutaneous manifestations in a young patient using clozapine for schizophrenia: a case report. |
2023-11-21 |
2023-11-29 |
Not clear |
| Marina Coelho Moraes de Brito, Maria Magalhães Vasconcelos Guedes, Janaíra da Silva Nascimento, Victoria Pimentel Jatobá, Murilo Pereira Alves Junior, Adrianne de Carvalho Lira, Pedro Alves da Cruz Gouvei. Diffuse Large B-Cell Lymphoma with Cutaneous Manifestations in a Young Patient Using Clozapine for Schizophrenia: A Case Report. The American journal of case reports. vol 24. 2023-11-21. PMID:37986560. |
case report we report a case of a 44-year-old woman diagnosed with schizophrenia 31 years previously, who had been taking clozapine since 2009, presenting with diffuse cutaneous nodules and subcutaneous masses accompanied by asthenia, dry cough, and a weight loss of 12 kg. |
2023-11-21 |
2023-11-29 |
Not clear |
| Anindya Kar, Thomas Nutting, Mohammad Ikram, Charles Sulliva. The clozapine conundrum: Navigating neutropenia and the pursuit of effective care in treatment-resistant schizophrenia. International journal of psychiatry in medicine. 2023-11-16. PMID:37971414. |
the clozapine conundrum: navigating neutropenia and the pursuit of effective care in treatment-resistant schizophrenia. |
2023-11-16 |
2023-11-20 |
Not clear |
| Carmen F M van Hooijdonk, Marieke van der Pluijm, Bart M de Vries, Matthijs Cysouw, Behrooz Z Alizadeh, Claudia J P Simons, Therese A M J van Amelsvoort, Jan Booij, Jean-Paul Selten, Lieuwe de Haan, Frederike Schirmbeck, Elsmarieke van de Giesse. The association between clinical, sociodemographic, familial, and environmental factors and treatment resistance in schizophrenia: A machine-learning-based approach. Schizophrenia research. vol 262. 2023-11-11. PMID:37950936. |
prediction of treatment resistance in schizophrenia (trs) would be helpful to reduce the duration of ineffective treatment and avoid delays in clozapine initiation. |
2023-11-11 |
2023-11-20 |
Not clear |
| Jonathan M Meye. Making sense of norclozapine levels: 3 clinical axioms. Schizophrenia research. 2023-11-09. PMID:37945386. |
laboratories commonly provide norclozapine concentrations when a plasma clozapine level is requested, but the appropriate use of this information for the treatment of individuals with schizophrenia is not always clear. |
2023-11-09 |
2023-11-20 |
Not clear |
| Michelle V Daniels, Suvira Ramlal. Clozapine monitoring at a specialised psychiatric hospital: A retrospective chart review. The South African journal of psychiatry : SAJP : the journal of the Society of Psychiatrists of South Africa. vol 29. 2023-11-06. PMID:37928939. |
clozapine is the only food and drug administration (fda) and national institute for care and excellence (nice) approved drug for treatment-resistant schizophrenia (trs). |
2023-11-06 |
2023-11-08 |
Not clear |
| Atakan Yuce. Critical Feedback on Article by Lee and Colleagues: "Long-Term Outcome of Clozapine in Treatment-Resistant Schizophrenia". Journal of clinical psychopharmacology. vol 43. issue 6. 2023-11-06. PMID:37930219. |
critical feedback on article by lee and colleagues: "long-term outcome of clozapine in treatment-resistant schizophrenia". |
2023-11-06 |
2023-11-08 |
Not clear |
| Myung A Lee, Philip Cola, Karu Jayathilake, Herbert Y Meltze. Reply to Dr Yucel's Comments on the Article "Long-term Outcome of Clozapine in Treatment-Resistant Schizophrenia". Journal of clinical psychopharmacology. vol 43. issue 6. 2023-11-06. PMID:37930220. |
reply to dr yucel's comments on the article "long-term outcome of clozapine in treatment-resistant schizophrenia". |
2023-11-06 |
2023-11-08 |
Not clear |
| Jonathan Gerard, Hsueh Ching Seow, Deborah Hui Yi Tan, Yuen Mei See, Jie Yin Yee, Boon Tat Ng, Charmaine Tang, Jimmy Le. Obsessive-Compulsive Symptoms and Disorder in Clozapine-treated Schizophrenia. Spanish journal of psychiatry and mental health. 2023-11-02. PMID:37918717. |
furthermore, the use of clozapine in treatment-resistant schizophrenia has been thought to induce or aggravate these disorders. |
2023-11-02 |
2023-11-08 |
Not clear |
| Maria Colao, Clara Migotto, Susanna Gilardi, Fulvia Erasmi, Ilaria Borettaz, Marianna Boso, Enrico Giuliani, Renza Tibold. [Clozapine-induced Tubulointerstitial Nephritis]. Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia. vol 40. issue 4. 2023-11-01. PMID:37910212. |
clozapine is a second generation atypical antipsycothic usually used for the treatment of schizophrenia resistant to other types of treatment; it can cause severe adverse effects among which the best known is a severe and potentially fatal neutropenia, furthermore a series of uncommon adverse events are recognized including hepatitis, pancreatitis, vasculitis. |
2023-11-01 |
2023-11-08 |
Not clear |
| Giulia Blandino, Mara Fiorani, Barbara Canonico, Rita De Matteis, Andrea Guidarelli, Mariele Montanari, Gloria Buffi, Lucia Coppo, Elias S J Arnér, Orazio Canton. Clozapine suppresses NADPH oxidase activation, counteracts cytosolic H Redox biology. vol 67. 2023-10-30. PMID:37866162. |
clozapine suppresses nadph oxidase activation, counteracts cytosolic h long-term treatment of schizophrenia with clozapine (clz), an atypical antipsychotic drug, is associated with an increased incidence of metabolic disorders mediated by poorly understood mechanisms. |
2023-10-30 |
2023-11-08 |
Not clear |
| Victor Hugo Schaly Cordova, Amelia Dias Teixeira, Ana Paula Anzolin, Roberta Moschetta, Paulo Silva Belmonte-de-Abre. Inflammatory markers in outpatients with schizophrenia diagnosis in regular use of clozapine: a cross-sectional study. Frontiers in psychiatry. vol 14. 2023-10-26. PMID:37876624. |
inflammatory markers in outpatients with schizophrenia diagnosis in regular use of clozapine: a cross-sectional study. |
2023-10-26 |
2023-11-08 |
Not clear |
| Victor Hugo Schaly Cordova, Amelia Dias Teixeira, Ana Paula Anzolin, Roberta Moschetta, Paulo Silva Belmonte-de-Abre. Inflammatory markers in outpatients with schizophrenia diagnosis in regular use of clozapine: a cross-sectional study. Frontiers in psychiatry. vol 14. 2023-10-26. PMID:37876624. |
it is known that inflammation worsen the course of schizophrenia and induce high clozapine serum levels. |
2023-10-26 |
2023-11-08 |
Not clear |
| Victor Hugo Schaly Cordova, Amelia Dias Teixeira, Ana Paula Anzolin, Roberta Moschetta, Paulo Silva Belmonte-de-Abre. Inflammatory markers in outpatients with schizophrenia diagnosis in regular use of clozapine: a cross-sectional study. Frontiers in psychiatry. vol 14. 2023-10-26. PMID:37876624. |
however, no study evaluated this change in function of clozapine daily dose in schizophrenia. |
2023-10-26 |
2023-11-08 |
Not clear |
| Victor Hugo Schaly Cordova, Amelia Dias Teixeira, Ana Paula Anzolin, Roberta Moschetta, Paulo Silva Belmonte-de-Abre. Inflammatory markers in outpatients with schizophrenia diagnosis in regular use of clozapine: a cross-sectional study. Frontiers in psychiatry. vol 14. 2023-10-26. PMID:37876624. |
we assessed the correlation between inflammation and severity symptoms in patients with schizophrenia that take and do not take clozapine. |
2023-10-26 |
2023-11-08 |
Not clear |
| Chithra Uppinkudru, Vanteemar S Sreeraj, Shyam Sunder Arumugham, Samir K Praharaj, Nishant Goyal, Preeti Sinha, Jagadisha Thirthall. Is ECT better than clozapine for treatment-resistant schizophrenia? Asian journal of psychiatry. vol 90. 2023-10-23. PMID:37871364. |
is ect better than clozapine for treatment-resistant schizophrenia? |
2023-10-23 |
2023-11-08 |
Not clear |
| Andrea Mallorquí, Cristina Oliveira, Jose Rios, Maria Pilar Isla-Pera, Joaquin Gil-Badenes, Silvia Amoretti, Miguel Bernardo, Eduard Vieta, Eduard Parellada, Marina Garriga, Clemente García-Riz. Nurse-led lifestyle intervention in a cohort of schizophrenia patients treated with clozapine. Archives of psychiatric nursing. vol 46. 2023-10-16. PMID:37813503. |
nurse-led lifestyle intervention in a cohort of schizophrenia patients treated with clozapine. |
2023-10-16 |
2023-11-08 |
Not clear |
| Andrea Mallorquí, Cristina Oliveira, Jose Rios, Maria Pilar Isla-Pera, Joaquin Gil-Badenes, Silvia Amoretti, Miguel Bernardo, Eduard Vieta, Eduard Parellada, Marina Garriga, Clemente García-Riz. Nurse-led lifestyle intervention in a cohort of schizophrenia patients treated with clozapine. Archives of psychiatric nursing. vol 46. 2023-10-16. PMID:37813503. |
here, we aim to evaluate the physical health effects of a nurse-led non-pharmacological intervention program in patients with a diagnosis of schizophrenia treated with clozapine. |
2023-10-16 |
2023-11-08 |
Not clear |
| Andrea Mallorquí, Cristina Oliveira, Jose Rios, Maria Pilar Isla-Pera, Joaquin Gil-Badenes, Silvia Amoretti, Miguel Bernardo, Eduard Vieta, Eduard Parellada, Marina Garriga, Clemente García-Riz. Nurse-led lifestyle intervention in a cohort of schizophrenia patients treated with clozapine. Archives of psychiatric nursing. vol 46. 2023-10-16. PMID:37813503. |
thirty-one outpatients from the outpatient clinical facility of hospital clinic in barcelona, spain diagnosed with schizophrenia and other psychotic disorders receiving clozapine treatment were enrolled in a prospective interventional study, comprising an 8-week group program of therapeutic education in a healthy lifestyle. |
2023-10-16 |
2023-11-08 |
Not clear |
| Jonathan G Leung, Lusi Zhang, Matej Markota, Vicki L Ellingrod, Danielle J Gerberi, Jeffrey R Bisho. A systematic review of clozapine-associated inflammation and related monitoring. Pharmacotherapy. 2023-10-16. PMID:37842767. |
clozapine is an effective antipsychotic medication used for treatment-resistant schizophrenia. |
2023-10-16 |
2023-11-08 |
Not clear |